(no title)
benjaminjt | 4 years ago
> The University of Texas Hexapro vaccine candidate – delivered via the UQ-developed and Vaxxas-commercialised high-density microarray patch (HD-MAP) – provided protection against COVID-19 disease with a single, pain-free ‘click’ from a pocket-sized applicator.
[0] https://stories.uq.edu.au/news/2021/needle-free-covid-19-vac...
No comments yet.